Viewing nowCombinationTwinmax Tablets 40/5 Milligrams
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Korea Prime Pharmaceuticals Co., Ltd.

MFDS item code 201605805 · Approved 2016.09.30 · Insurance code 663607110
Treatment of essential hypertension not controlled with monotherapy
Patients with essential hypertension can effectively manage their blood pressure with this medication when their blood pressure is not adequately controlled with either amlodipine or telmisartan monotherapy. It helps to reliably lower blood pressure, aids in the prevention of cardiovascular diseases, and plays an important role in patient health management. Therefore, this medication is used for the treatment of essential hypertension that is not well controlled.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan) before administering this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older patients: The usual amlodipine dosage is recommended for older patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, and should not be taken by women who are pregnant or might become pregnant. This medication should not be administered to patients with specific conditions, such as liver impairment, obstructive biliary disease, severe hypotension, serious heart conditions, diabetes, or moderate to severe kidney impairment. Patients with primary aldosteronism, aortic stenosis, hypertrophic obstructive cardiomyopathy, impaired liver function, gastrointestinal disease, renal artery hypertension, etc. should use this medication with caution, especially elderly patients or those with renal failure requiring dialysis. Common side effects such as dizziness or peripheral edema may occur while taking this medication, and serious side effects have been reported less frequently; hence, any unusual symptoms should be reported to a medical professional immediately. Taking this medication during pregnancy can lead to severe issues such as decreased fetal kidney function, reduction in amniotic fluid, and delayed skull ossification, thus it should be stopped immediately and alternative treatment should be initiated upon confirmation of pregnancy. It is also recommended that women who are breastfeeding do not take this medication and must consult a healthcare professional if they are nursing. The safety and efficacy of this medication have not been sufficiently established in children under 18 years, so it is not recommended for use in this population. Exceeding the prescribed dosage can result in hypotension, dizziness, and changes in heart rate; therefore, adhering to the recommended dosage is important, and any unusual symptoms should prompt an immediate visit to a medical facility. This medication may interact with other drugs, so it's essential to inform healthcare professionals regarding any other medications being taken, particularly potassium supplements, diuretics, lithium, digoxin, and grapefruit juice. Dizziness or drowsiness may occur when driving or operating machinery, so caution is advised. Store this medication out of reach of children, and it's important to keep it sealed after opening to maintain product quality.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that protects it from light. Additionally, it should be kept at room temperature, between 1 to 30 degrees Celsius, to preserve its effectiveness.
White and light gray, double convex oval-shaped tablet
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Korea Prime Pharmaceuticals Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.